To include your compound in the COVID-19 Resource Center, submit it here.

2Q09 milestones

2Q09 milestones

Company Product Indication Milestone Milestone date
Advanced Life (NASDAQ:ADLS) Cethromycin Community-acquired pneumonia (CAP) FDA panel 6/2/09
AGI Therapeutics (ISE:A9I; LSE:AGI) Rezular arverapamil (AGI-003) Diarrhea-predominant irritable bowel syndrome (IBS-D) Prelim Ph III data 2Q09
Allergan (NYSE:AGN) Botox botulinum toxin Prevent headaches in patients with chronic migraine Final Ph III data; submit sBLA Mid-2009
Amylin (NASDAQ:AMLN)/ Alkermes (NASDAQ:ALKS)/ Eli Lilly (NYSE:LLY) Exenatide once weekly Type II

Read the full 886 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers